EMEA-001990-PIP01-16-M05 - paediatric investigation plan

fenfluramine hydrochloride
PIPHuman

Key facts

Invented name
Fintepla
Active Substance
fenfluramine hydrochloride
Therapeutic area
Neurology
Decision number
P/0390/2022
PIP number
EMEA-001990-PIP01-16-M05
Pharmaceutical form(s)
Oral solution
Condition(s) / indication(s)
Treatment of Dravet syndrome
Route(s) of administration
  • Oral use
  • Gastric use
Contact for public enquiries

UCB Pharma SA

Email: ucbcares.uk@ucb.com
Tel. +44 175777100
 

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page